Title of the Innovative Proposal: A Distributed Immune System for Global Food Supply Chains: 15-Minute, Phone-Read Pathogen Detection from Farm to Table
Reem Mahrat is the Founder and CEO of EazeBio, Inc., a California company putting a clinical lab in every hand: lab-grade biomarker testing at home, with results in minutes and AI that turns each result into insight. A chemical engineer by training, Reem is a four-time founder with three exits: RamanID (acquired by NomadX), Calico Bio Labs (acquired by Abcam) and Mariposa (acquired by Spring Bio, later Roche). She is a named inventor on more than 13 patent applications, and her team's work on de novo protein biosensors and rapid Tau testing is published in the Journal of Fluorescence.
Reem advises at Stanford SPARK, serves as Entrepreneur-in-Residence at Daybreak Labs, and was named a Marquis Who's Who Top Scientist in 2024. She is also the author of five books. Her mission is simple: rigor and access should never be a trade-off.